16.11.2012 Views

7. panická porucha

7. panická porucha

7. panická porucha

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Literatura<br />

Alexander PE: Management of panic disorders. J Psychoactive Drugs 1991; 23: 329-<br />

333.<br />

Altshuler LL: Fluoxetine-associated panic attacks. J Clin Psychopharmacol 1994; 14:<br />

433-434.<br />

American Psychiatric Association: Practice guideline for the treatment of pacients<br />

with panic disorder. Am J Psychiatry 1998; 155(suppl 5): 34s.<br />

Andersch S, Rosenberg NK, Kullingsjo H et al. Efficacy and safety of alprazolam,<br />

imipramine and placebo in treating panic disorder: a Scandinavian multicenter study.<br />

Acta Psychiatr Scand 1991; 365(suppl): 18-2<strong>7.</strong><br />

Asmundson GJG a Taylor S: Anxiety disorders: Panic disorder with and without<br />

agoraphobia. In: Tasman A, Kay J, Lieberman JA (eds): Psychiatry, Second Edition,<br />

Wiley & Sons, Chichester 2003; 1281-129<strong>7.</strong>.<br />

Bakish D, Saxena BM, Bowen R, D´Souza JD: Reversible monoamine oxidaze -<br />

inhibitors in panic disorder. Clin Neuropharmacol 1993; 16 (suppl 2): S77-S82.<br />

Bakish, D., Filteau, M.J., Charbonneau, Y. et al. A double-blind, placebo-controlled<br />

trial comparing fluvoxamine and imipramine in the treatment of panic disorder with<br />

or without agoraphobia. In: Neuropsychopharmacology, pt.2, XIX th CINP, June 27-<br />

July 1, 1994, Washington, DC, Abstract 0-27-38<br />

Bakish D, Hooper CL, Filteau MJ, et al. A double blind placebo-controlled trial<br />

comparing fluvoxamine and imipramine in the treatment of panic disorder with or<br />

without agoraphobia. Psychopharmacology Bulletin 1996; 32:135-141<br />

Ballenger JC: Panic disorder in the medical setting. J Clin Psychiatry 1997; 58 (suppl<br />

2): 13-1<strong>7.</strong><br />

Ballenger, J.C.: Comorbidity of panic and depression: Implications for clinical<br />

management. International Journal of Clinical Psychopharmacology 1998; 13 (suppl<br />

4): S13-17<br />

Ballenger, J.C.: (On behalf of Paroxetine Panic Disorder Study Group), Wheadon DE,<br />

Steiner M, Bushnell W, Gergel I. Double blind, fixed dosese, placebo-controlled<br />

study of paroxetine in the treatment of panic disorder.Am J Psychiatry 1998;155: 36-<br />

42<br />

Ballenger, J.C.: Selective serotonin reuptake inhibitors (SSRIs) in panic disorder. In:<br />

D.Nutt, J. Ballenger a J.P. Lepine (eds.): Panic disorder: clinical diagnosis,<br />

management and mechanisms. Dunitz, London. 1999; 159-178<br />

Ballenger, J.C.: Panic disorder and agoraphobia. In: M.G.Gelder, J.J.Lopez-Ibor, N.<br />

Andreasen (eds.): New Oxford Textbook of Psychiatry. Oxford University Press.<br />

Oxford 2000, 807-822<br />

Ballenger, J.C., Burrows, G.D., Dupont, R.L.: Alprazolam in Panic Disorder and<br />

Agoraphobia: Results from a Multicenter Trial. Arch. Gen. Psychiatry 1988: 45: s.<br />

413-422<br />

35

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!